ETE Metrics

NYS Progress to End the AIDS Epidemic by the End of 2020

NEW HIV INFECTIONS (INCIDENCE)
Reduce the number of estimated new HIV infections to
HIV STATUS AWARE
Increase the percentage of people living with HIV who know their serostatus to at least
NEW HIV DIAGNOSES
Reduce the number of new HIV diagnoses by 55% to

2020 Target 98%

2018 Actual 91%

2020 Target 1,515

2018 Actual 2,481

(estimated)
Data for this metric are produced using a CDC method and associated program that were introduced in 2017. Source: Song R, et al., 2017.
Data for this metric are produced using a CDC method and associated program that were introduced in 2017. Source: Song R, et al., 2017.
Number of newly diagnosed HIV cases reported. (NHAS 2020 Goal: 25%)
NYS HIV Surveillance System
NEWLY DIAGNOSED HIV - PERSONS WHO INJECT DRUGS
Reduce the percentage of persons newly diagnosed with HIV who indicate a history of injection drug use to
CONCURRENT AIDS DIAGNOSIS
Reduce the proportion of persons with a diagnosis of AIDS within 30 days of HIV diagnosis to
LINKAGE TO CARE
Increase the percentage of newly diagnosed persons linked to HIV medical care within 30 days of diagnosis to at least

2020 Target 2.8%

2018 Actual 4.9%

2020 Target 15.0%

2018 Actual 20.9%

2020 Target 90%

2018 Actual 82%

Includes persons who indicate IDU and MSM/IDU history. NYS HIV Surveillance System
HIV infection with simultaneous AIDS diagnosis, or AIDS diagnosis (stage 3 HIV) within 30 days.
NYS HIV Surveillance System
Newly diagnosed with any VL, CD4 or genotype within 30 days of diagnosis by diagnosis year.NHAS 2020 Goal: 85%
NYS HIV Surveillance System
RECEIVING HIV MEDICAL CARE
Increase the percentage of persons living with diagnosed HIV (PLWDH) who receive HIV medical care to
VIRAL SUPPRESSION - NEWLY DIAGNOSED HIV
Increase the percentage of persons newly diagnosed with HIV who reach viral load suppression within 3 months of diagnosis to
VIRAL SUPPRESSION - PLWDH
Increase the percentage of persons living with diagnosed HIV with suppressed viral load to

2020 Target 90%

2018 Actual 84%

2020 Target 75%

2018 Actual 55%

2020 Target 85%

2018 Actual 75%

Any VL, CD4 or genotype test in a calendar year
NYS HIV Surveillance System
VL test suppressed (<200 copies/mL) within 91 days from the date of HIV diagnosis.
NYS HIV Surveillance System
Last VL test in calendar year is non-detectable or <200 copies/ml. (NHAS 2020 Goal = 80%).
NYS HIV Surveillance System.
VIRAL SUPPRESSION - RECEIVING HIV MEDICAL CARE
Increase the percentage of PLWDH who receive care with suppressed viral load to
SUSTAINED VIRAL LOAD SUPPRESSION
Increase the percentage of PLWDH with sustained viral suppression to
TIME TO AIDS DIAGNOSIS
Reduce the percentage of persons newly diagnosed with HIV who progress to AIDS in 2 years by 50% to

2020 Target 95%

2018 Actual 89%

2020 Target 75%

2018 Actual 67%

2020 Target 5.1%

2016 Actual 5.9%

Last VL test in calendar year is non detectable or <200 copies/ml
NYS HIV Surveillance System
Result of <200 copies/mL on all viral load tests in the previous 2 years, among those with at least 2 viral load tests in the previous 2 years. NYS HIV Surveillance System.
AIDS diagnosis within 2 years of HIV diagnosis
NYS HIV Surveillance System
HIV RELATED DEATHS
Reduce the percentage of deaths among PLWDH directly related to HIV to 20%
STIGMA
Decrease stigma experienced among PLWDH with diagnosed HIV by at least
PrEP UTILIZATION
Increase the number of individuals filling prescriptions for PrEP to

2020 Target 20%

2017 Actual 27%

2020 Target 25%

2017 Actual 38%

2020 Target 65,000

2018 Actual 31,964

Deaths among people with diagnosed HIV are considered to be “HIV-related” if the underlying cause of death was HIV. NYS HIV Surveillance System.
Based on results of a 10 question scale looking at 4 dimensions of stigma (personalized stigma, disclosure concerns, negative self-image, and perceived public attitudes about people with HIV). NYS Medical Monitoring Project
Number of individuals filling at least one prescription for Truvada within the calendar year. Source: IDV (Integrated Dataverse) from Symphony Health and the NYS Medicaid Data Warehouse.
PrEP UTILIZATION - MEDICAID
Increase the number of Medicaid recipients filling prescriptions for PrEP to

2020 Target 30,000

2018 Actual 8,085

Number of Medicaid recipients filling at least one prescription for Truvada within the calendar year. Source: NYS Medicaid Data Warehouse
  • NYS DOH AIDS Institute, Division of HIV/STD Epidemiology, Evaluation & Partner Services

*Data displayed for New York City comes from the NYC DOHMH HIV Surveillance System, unless otherwise noted, reported as of March 31, 2019. 2020 NYS statewide goals are displayed in all instances except for the NYC-specific ETE 2020 goals for new HIV infections (800) and new HIV diagnoses (1,350). NYC data is also viewable by race/ethnicity for select metrics, using the drop down menus below each chart.

ETE Metrics

NYC Progress to End the AIDS Epidemic by the End of 2020

NEW HIV INFECTIONS (INCIDENCE)
Reduce the number of estimated new HIV infections to
HIV STATUS AWARE
Increase the percentage of people living with HIV who know their serostatus to at least
NEW HIV DIAGNOSES
Reduce the number of new HIV diagnoses to

2020 Target 800 (NYC)

2018 Actual 1,600 (NYC)

2020 Target 98%

2018 Actual 93% (NYC)

2020 Target 1,350 (NYC)

2018 Actual 1,917 (NYC)

(estimated)
Data for this metric are produced using a CDC method and associated program that were introduced in 2017. Source: Song R, et al., 2017.

Data for this metric are produced using a CDC method and associated program that were introduced in 2017. Source: Song R, et al., 2017.

Number of newly diagnosed HIV cases reported.
NYC DOHMH HIV Surveillance System

NEWLY DIAGNOSED HIV - PERSONS WHO INJECT DRUGS
Reduce the percentage of persons newly diagnosed with HIV who indicate a history of injection drug use to
CONCURRENT AIDS DIAGNOSIS
Reduce the proportion of persons with a diagnosis of AIDS within 31 days of HIV diagnosis to
LINKAGE TO CARE
Increase the percentage of newly diagnosed persons linked to HIV medical care within 30 days of diagnosis to at least

2020 Target 2.8%

2018 Actual 3.1% (NYC)

2020 Target 15.0%

2018 Actual 19.4% (NYC)

2020 Target 90%

2018 Actual 84% (NYC)

Includes persons who indicate IDU and MSM/IDU history. NYC DOHMH HIV Surveillance System

HIV infection with simultaneous AIDS diagnosis, or AIDS diagnosis (stage 3 HIV) within 31 days.
NYC DOHMH HIV Surveillance System

Newly diagnosed with any VL, CD4 or genotype within 30 days of diagnosis by diagnosis year.NHAS 2020 Goal: 85%
NYC DOHMH HIV Surveillance System

RECEIVING HIV MEDICAL CARE
Increase the percentage of persons living with diagnosed HIV (PLWDH) who receive HIV medical care to
VIRAL SUPPRESSION - NEWLY DIAGNOSED HIV
Increase the percentage of persons newly diagnosed with HIV who reach viral load suppression within 3 months of diagnosis to
VIRAL SUPPRESSION - PLWDH
Increase the percentage of persons living with diagnosed HIV with suppressed viral load to

2020 Target 90%

2018 Actual 93% (NYC)

2020 Target 75%

2018 Actual 53% (NYC)

2020 Target 85%

2018 Actual 83% (NYC)

Any VL, CD4 or genotype test in NYC DOHMH HIV Surveillance System in a calendar year

VL test suppressed (<200 copies/mL) within 91 days from the date of HIV diagnosis.
NYC DOHMH HIV Surveillance System

Last VL in calendar year is undetectable or <200 copies/mL. NYC DOHMH HIV Surveillance System.

VIRAL SUPPRESSION - RECEIVING HIV MEDICAL CARE
Increase the percentage of PLWDH who receive care with suppressed viral load to
SUSTAINED VIRAL LOAD SUPPRESSION
Increase the percentage of PLWDH with sustained viral suppression to
TIME TO AIDS DIAGNOSIS
Reduce the percentage of persons newly diagnosed with HIV who progress to AIDS in 2 years by 50% to

2020 Target 95%

2018 Actual 87% (NYC)

2020 Target 75%

2018 Actual 67% (NYC)

2020 Target 5.1%

2016 Actual 6.5% (NYC)

Last VL in calendar year is undetectable or <200 copies/mL. NYC DOHMH HIV Surveillance System.

Result of <200 copies/mL on all viral load tests in the previous 2 years, among those with at least 2 viral load tests in the previous 2 years. NYC DOHMH HIV Surveillance System.

AIDS diagnosis within 2 years of HIV diagnosis
NYC DOHMH HIV Surveillance System

HIV RELATED DEATHS
Reduce the percentage of deaths directly related to HIV to 20%
STIGMA
Decrease stigma experienced among PLWDH with diagnosed HIV by at least
PrEP UTILIZATION
Increase the number of individuals filling prescriptions for PrEP to

2020 Target 20%

2017 Actual 28% (NYC)

2020 Target 25%

2017 Actual 38% (NYC)

Deaths among people with HIV are considered to be “HIV-related” if the underlying cause of death was HIV. NYC DOHMH HIV Surveillance System.

Race/ethnicity data unavailable
Based on results of a 10 question scale looking at 4 dimensions of stigma (personalized stigma, disclosure concerns, negative self-image, and perceived public attitudes about people with HIV). NYC Medical Monitoring Project
Race/ethnicity data not shown**
Number of individuals filling at least one prescription for Truvada within the calendar year. Source: IDV (Integrated Dataverse) from Symphony Health and the NYS Medicaid Data Warehouse.
PrEP UTILIZATION - MEDICAID
Increase the number of Medicaid recipients filling prescriptions for PrEP to
Race/ethnicity data not shown**
Number of Medicaid recipients filling at least one prescription for Truvada within the calendar year. Source: NYS Medicaid Data Warehouse

*Data displayed for New York City comes from the NYC DOHMH HIV Surveillance System, unless otherwise noted, reported as of March 31, 2019. 2020 NYS statewide goals are displayed in all instances except for the NYC-specific ETE 2020 goals for new HIV infections (800) and new HIV diagnoses (1,350). NYC data is also viewable by race/ethnicity for select metrics, using the drop down menus below each chart.

**PrEP use by race/ethnicity data not shown on this page due to large number of individuals with missing/unknown race/ethnicity. View the Dashboard’s PrEP use visualization to view these data.